Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Oral Contrast Agent Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Oral Contrast Agent Market Status and Forecast (2016-2027)
      • 1.3.2 Global Oral Contrast Agent Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Oral Contrast Agent Supply by Company

    • 2.1 Global Oral Contrast Agent Sales Volume by Company
    • 2.2 Global Oral Contrast Agent Sales Value by Company
    • 2.3 Global Oral Contrast Agent Price by Company
    • 2.4 Oral Contrast Agent Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Oral Contrast Agent Market Status by Category

    • 3.1 Oral Contrast Agent Category Introduction
      • 3.1.1 Barium-based Contrast Media
      • 3.1.2 Iodinated Contrast Media
      • 3.1.3 Gadolinium-based Contrast Media
      • 3.1.4 Microbubble Contrast Media
    • 3.2 Global Oral Contrast Agent Market by Category
      • 3.2.1 Global Oral Contrast Agent Sales Volume by Category (2016-2021)
      • 3.2.2 Global Oral Contrast Agent Sales Value by Category (2016-2021)
      • 3.2.3 Global Oral Contrast Agent Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Oral Contrast Agent Market Status by End User/Segment

    • 4.1 Oral Contrast Agent Segment by End User/Segment
      • 4.1.1 Cardiovascular Disorders
      • 4.1.2 Cancer
      • 4.1.3 Gastrointestinal Disorders
      • 4.1.4 Musculoskeletal Disorders
      • 4.1.5 Neurological Disorders
      • 4.1.6 Nephrological Disorders
    • 4.2 Global Oral Contrast Agent Market by End User/Segment
      • 4.2.1 Global Oral Contrast Agent Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Oral Contrast Agent Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Oral Contrast Agent Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Oral Contrast Agent Market Status by Region

    • 5.1 Global Oral Contrast Agent Market by Region
      • 5.1.1 Global Oral Contrast Agent Sales Volume by Region
      • 5.1.2 Global Oral Contrast Agent Sales Value by Region
    • 5.2 North America Oral Contrast Agent Market Status
    • 5.3 Europe Oral Contrast Agent Market Status
    • 5.4 Asia Pacific Oral Contrast Agent Market Status
    • 5.5 Central & South America Oral Contrast Agent Market Status
    • 5.6 Middle East & Africa Oral Contrast Agent Market Status

    6 North America Oral Contrast Agent Market Status

    • 6.1 North America Oral Contrast Agent Market by Country
      • 6.1.1 North America Oral Contrast Agent Sales Volume by Country (2016-2021)
      • 6.1.2 North America Oral Contrast Agent Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Oral Contrast Agent Market Status

    • 7.1 Europe Oral Contrast Agent Market by Country
      • 7.1.1 Europe Oral Contrast Agent Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Oral Contrast Agent Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Oral Contrast Agent Market Status

    • 8.1 Asia Pacific Oral Contrast Agent Market by Country
      • 8.1.1 Asia Pacific Oral Contrast Agent Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Oral Contrast Agent Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Oral Contrast Agent Market Status

    • 9.1 Central & South America Oral Contrast Agent Market by Country
      • 9.1.1 Central & South America Oral Contrast Agent Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Oral Contrast Agent Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Oral Contrast Agent Market Status

    • 10.1 Middle East & Africa Oral Contrast Agent Market by Country
      • 10.1.1 Middle East & Africa Oral Contrast Agent Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Oral Contrast Agent Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Oral Contrast Agent Manufacturing Cost Analysis
    • 11.5 Oral Contrast Agent Sales Channel and Distributors Analysis
      • 11.5.1 Oral Contrast Agent Sales Channel
      • 11.5.2 Oral Contrast Agent Distributors
    • 11.6 Oral Contrast Agent Downstream Major Buyers

    12 Global Oral Contrast Agent Market Forecast by Category and by End User/Segment

    • 12.1 Global Oral Contrast Agent Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Oral Contrast Agent Forecast by Category
      • 12.2.1 Global Oral Contrast Agent Sales Volume Forecast by Category
      • 12.2.2 Global Oral Contrast Agent Sales Value Forecast by Category
      • 12.2.3 Global Oral Contrast Agent Price Forecast by Category
    • 12.3 Global Oral Contrast Agent Forecast by End User/Segment
      • 12.3.1 Global Oral Contrast Agent Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Oral Contrast Agent Sales Value Forecast by End User/Segment
      • 12.3.3 Global Oral Contrast Agent Price Forecast by End User/Segment

    13 Global Oral Contrast Agent Market Forecast by Region/Country

    • 13.1 Global Oral Contrast Agent Market Forecast by Region (2022-2027)
      • 13.1.1 Global Oral Contrast Agent Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Oral Contrast Agent Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Unijules Life Sciences (India)
      • 14.1.1 Company Information
      • 14.1.2 Oral Contrast Agent Product Introduction
      • 14.1.3 Unijules Life Sciences (India) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Taejoon Pharm (South Korea)
      • 14.2.1 Company Information
      • 14.2.2 Oral Contrast Agent Product Introduction
      • 14.2.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Spago Nanomedicine (Sweden)
      • 14.3.1 Company Information
      • 14.3.2 Oral Contrast Agent Product Introduction
      • 14.3.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Magnus Health (India)
      • 14.4.1 Company Information
      • 14.4.2 Oral Contrast Agent Product Introduction
      • 14.4.3 Magnus Health (India) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Lantheus (US)
      • 14.5.1 Company Information
      • 14.5.2 Oral Contrast Agent Product Introduction
      • 14.5.3 Lantheus (US) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Jodas (India)
      • 14.6.1 Company Information
      • 14.6.2 Oral Contrast Agent Product Introduction
      • 14.6.3 Jodas (India) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 J.B. Chemicals and Pharmaceuticals (India)
      • 14.7.1 Company Information
      • 14.7.2 Oral Contrast Agent Product Introduction
      • 14.7.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Guerbet (France)
      • 14.8.1 Company Information
      • 14.8.2 Oral Contrast Agent Product Introduction
      • 14.8.3 Guerbet (France) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 GE Healthcare (US)
      • 14.9.1 Company Information
      • 14.9.2 Oral Contrast Agent Product Introduction
      • 14.9.3 GE Healthcare (US) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Daiichi Sankyo (Japan)
      • 14.10.1 Company Information
      • 14.10.2 Oral Contrast Agent Product Introduction
      • 14.10.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Bracco Imaging (Italy)
    • 14.12 Bayer HealthCare (Germany)

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Oral Contrast Agent market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Oral Contrast Agent market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Barium-based Contrast Media
      Iodinated Contrast Media
      Gadolinium-based Contrast Media
      Microbubble Contrast Media

      Segmented by End User/Segment
      Cardiovascular Disorders
      Cancer
      Gastrointestinal Disorders
      Musculoskeletal Disorders
      Neurological Disorders
      Nephrological Disorders

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Unijules Life Sciences (India)
      Taejoon Pharm (South Korea)
      Spago Nanomedicine (Sweden)
      Magnus Health (India)
      Lantheus (US)
      Jodas (India)
      J.B. Chemicals and Pharmaceuticals (India)
      Guerbet (France)
      GE Healthcare (US)
      Daiichi Sankyo (Japan)
      Bracco Imaging (Italy)
      Bayer HealthCare (Germany)
      Buy now